Skip to content
Life sciences consumables, equipment and services, delivered across Saudi Arabia.
Human Cytosolic Phospholipase A2-alpha (cPLA2a) ELISA Kit
  • Human Cytosolic Phospholipase A2-alpha (cPLA2a) ELISA Kit
Assay Genie

Human Cytosolic Phospholipase A2-alpha (cPLA2a) ELISA Kit

Price on request

SKUPriceQuantity
HUDL00653

Price on request

Description

This description has not been verified against the manufacturer's datasheet. Check the datasheet before you order, or ask us to confirm a specification. Ask us to confirm

Researchers studying phospholipid metabolism and eicosanoid signaling pathways can use this immunoassay kit from Assay Genie to measure cytosolic phospholipase A2-alpha in human-derived samples. The cytosolic phospholipase A2-alpha enzyme, also known as PLA2G4A or cPLA2α, plays a central role in liberating arachidonic acid from membrane glycerophospholipids, making it a key target for studies of inflammation, oxidative stress signaling, and prostaglandin and leukotriene pathway regulation.

The kit accommodates human specimen types including serum fractions, plasma-derived samples, tissue homogenates, and additional body fluid matrices, enabling flexibility across biomarker profiling, disease mechanism research, and pharmacological screening workflows. With a 96-assay plate configuration, the procedure accommodates moderate-throughput investigations. Components are intended for research use only and should be handled according to standard laboratory practices for immunoassay reagents, including equilibration to room temperature before use and protection from contamination during pipetting steps.

Calcium-dependent Group IVA phospholipase A2 activity is investigated in inflammatory disease research, cardiovascular research models, and neuroinflammation studies, where quantitative monitoring of enzyme levels supports preclinical investigations and clinical sample characterization. This Assay Genie ELISA provides a reproducible tool for laboratories engaged in lipid mediator research, drug discovery screening programs, and translational biomarker validation efforts.